Internationally controlled medicines (ICM) are those listed in the Schedules of the international drug control treaties and those contained in the World Health Organization (WHO) Model List of Essential Medicines. They are essential to optimal health outcomes as based on scientific evidence. Palliative care medicines are listed in Section 2 of the WHO Model List.
The following statements may be standards to diverse systems:
• A number of essential CM are part of a comprehensive pharmacological approach to pain, dyspnea, as well as drug use disorder treatment. Access to CM for the treatment of these symptoms and condition is a component of the right to health.
• Availability of and accessibility to CM for medical purposes is dependent upon a system of services.
• All patients deserve quality healthcare, which includes CM, regardless of whether they live in rural and urban areas, of the level of healthcare system available - primary or tertiary care — of the setting: public, private hospital, clinic, home, or long-term care center.
Adapted from United Nations. Technical Guidance: Increasing access and availability of controlled medicines. Internet. Available at https://www.unodc.org/documents/drug-prevention-and-treatment/UNODC_2018_technical_guidance_on_promoting_access_at_national_level.pdf. Accessed on August 3, 2022.